Deutsche Bank: lowered Moderna (NASDAQ:MRNA) price target to $200By legume / March 2, 2023 / Deutsche Bank, Moderna Deutsche Bank: Moderna (NASDAQ:MRNA) has an uncertain outlook for sustainable earnings and lowered its price target to $200.